Allscripts Healthcare Solutions Inc. is set to pay nearly $9.75 million to settle claims of securities fraud, after the company allegedly overstated its ability to integrate its systems and products ...

DALLAS, Oct. 4 /PRNewswire/ -- From the floor of the National Association for Home Care's (NAHC) 29th Annual Conference & Exhibition, Allscripts (Nasdaq: MDRX) today introduced Allscripts Mobile ...

Boynton Beach, Fla.-based Surfside Non-Surgical Orthopedics filed a class action lawsuit against Allscripts after a ransomware attack limited the practice's access to Allscripts' products for a week.

Allscripts and Microsoft have joined forces to design a new clinical research model that leverages the EHR and other technologies clinicians use when providing treatment. Veradigm — Allscripts’ payer ...

Just one week after some of Allscripts’ services were shut down by ransomware, the EHR giant is facing a lawsuit for allegedly failing to secure its systems and data from cyberattacks. Allscripts went ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced preliminary 2019 financial results. The company anticipates bookings (1) for 2019 of between $1,090 million to ...

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) today announced preliminary financial results for the three and twelve months ended December 31, 2021.

Allscripts' push to diversify beyond a core business dominated by larger rivals is off to a slow start. Despite a few acquisitions, a collaboration with Microsoft and a renamed division that peddles ...

Allscripts is selling the net assets of its business segment for hospitals and large physician practices to N. Harris Computer Corp., a subsidiary of Constellation Software. The business segment ...

Allscripts Healthcare Solutions, Inc. MDRX is well poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust first-quarter 2021 performance, along ...

Fourth quarter GAAP diluted EPS of $2.14; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04; growth of 16% in non-GAAP diluted EPS to $0.72 Closed sale of ...